
Best mid-cap healthcare stocks to invest in 2025
Mid-cap healthcare blends innovation with scalability, offering investors exposure to diverse medical advances. These companies expand access, improve outcomes, and compound growth through focused execution. Telix Pharmaceuticals develops radiopharmaceuticals that diagnose and treat cancer with targeted precision, pairing imaging agents with therapeutic delivery. Krystal Biotech commercializes gene therapies for rare skin diseases using its HSV-1 platform, advancing patient care with validated, scalable genetic medicine. Hims & Hers Health operates a subscription telehealth platform across men’s and women’s care, dermatology, mental health, and weight management. These mid-cap healthcare leaders combine disciplined execution with durable growth potential. Our 2025 outlook highlights resilient operators positioned to compound value across niches.
Tags: stocks








